Log in to save to my catalogue

Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholin...

Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2195238033

Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity

About this item

Full title

Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity

Publisher

England: Taylor & Francis

Journal title

Journal of enzyme inhibition and medicinal chemistry, 2017-01, Vol.32 (1), p.789-797

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis

More information

Scope and Contents

Contents

We investigated the influence of bronchodilating β2-agonists on the activity of human acetylcholinesterase (AChE) and usual, atypical and fluoride-resistant butyrylcholinesterase (BChE). We determined the inhibition potency of racemate and enantiomers of fenoterol as a resorcinol derivative, isoetharine and epinephrine as catechol derivatives and s...

Alternative Titles

Full title

Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2195238033

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2195238033

Other Identifiers

ISSN

1475-6366

E-ISSN

1475-6374

DOI

10.1080/14756366.2017.1326109

How to access this item